B-Raf IN 2 |
| Katalog-Nr.GC64550 |
B-Raf IN 2 ist ein potenter und selektiver BRAF-Inhibitor, extrahiert aus dem Patent WO2021116055A1, Verbindung Ia. B-Raf IN 2 kann fÜr die Krebsforschung eingesetzt werden.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2649372-20-1
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
B-Raf IN 2 is a potent and selective BRAF inhibitor extracted from patent WO2021116055A1, compound Ia. B-Raf IN 2 can be used for the research of cancer[1].
B-Raf IN 2 shows considerably less paradoxial activation of the MAPK signaling pathway while retaining high potency[1].
[1]. Dolente C, et, al. New methylquinazolinone derivatives. WO2021116055A1.
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *